- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/14 - Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Patent holdings for IPC class A61P 9/14
Total number of patents in this class: 624
10-year publication summary
16
|
16
|
34
|
46
|
56
|
53
|
62
|
50
|
50
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Osaka University | 3293 |
8 |
Daiichi Sankyo Company, Limited | 1864 |
7 |
Kowa Company, Ltd. | 1193 |
7 |
The Johns Hopkins University | 5524 |
6 |
National University Corporation Hamamatsu University School of Medicine | 122 |
6 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
5 |
Kinki University | 233 |
5 |
Regeneron Pharmaceuticals, Inc. | 3978 |
5 |
The University of Tokyo | 4053 |
5 |
The Regents of the University of California | 19493 |
4 |
Boehringer Ingelheim International GmbH | 4756 |
4 |
Chugai Seiyaku Kabushiki Kaisha | 1315 |
4 |
Lunamed AG | 13 |
4 |
Mercator Medsystems, Inc. | 47 |
4 |
Morinaga Milk Industry Co., Ltd. | 357 |
4 |
Sanofi | 3935 |
4 |
Novartis AG | 11289 |
3 |
Centre National de La Recherche Scientifique | 10068 |
3 |
The Trustees of Columbia University in the City of New York | 3518 |
3 |
Amarin Pharmaceuticals Ireland Limited | 268 |
3 |
Other owners | 530 |